“…5,6,11,15,34,47,50, Sixteen of the full papers were published in languages other than English. 37,52,74,76,79,81,95,[97][98][99][100][101][102][103][104][105] Nineteen studies had duplicate publications; where this was the case 14,40,42,43,56,103,104, one paper was allocated as the primary publication (full paper if the duplicate was an abstract or letter; the published paper if the duplicate comprised data from the manufacturer's online trials database, the most recent publication, or the paper published in English) and used as the citation for the study throughout the review; 14,40,42,43,56,106,[131][132][133][134][135][136][137][138][139][140]142,143 relevant data were extracted from all publications where applicable. After full-paper screening, 42 studies (across 70 publications) met the inclusion criteria for the review of clinical effectiveness; the flow of studies through the review is given in Figure 1<...>…”